GlassScriptPhysician profile
Spencer Anderson
NPI 1982139176
$6,274.01
in general payments reported to CMS, 2019-2025
22 companies · $2,932 in 2025
The $2,932 reported for 2025 was more than what 89% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.18 · 2022: $204 · 2023: $396 · 2024: $2,726 · 2025: $2,932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,853 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,852.96 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $1,364.20 | 2023-2024 | |
| Polynovo North America LLC | $1,243.17 | 2023-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $776.05 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Smith+Nephew, INC. | $536.51 | 2024-2025 | Grafix, Grafix Xc, Stravix |
| Mentor Worldwide LLC | $368.44 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Motiva USA, LLC | $344.11 | 2025 | |
| Abbvie INC. | $285.84 | 2025 | |
| Lifenet Health | $280.99 | 2024-2025 | Theragenesis Wound Matrix |
| Aroa Biosurgery Incorporated | $227.73 | 2025 | |
| Kerecis Limited | $187.82 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $137.05 | 2024 | Restrata Wound Matrix |
| Solventum Corporation | $129.88 | 2024-2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Vertex Pharmaceuticals Incorporated | $127.53 | 2024-2025 | |
| Straumann USA LLC | $59.55 | 2025 | |
| Kci USA, INC. | $55.09 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $37.69 | 2025 | Arista |
| Heron Therapeutics, INC. | $20.71 | 2025 | Zynrelef |
| Innovation Technologies INC | $20.64 | 2024 | Irrisept |
| Hydrofera LLC | $20.08 | 2025 | Hydrofera Blue |
| Lilly USA, LLC | $17.46 | 2025 | Zepbound |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.18 | 2021 | |
| Axogen | $16.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.